Back to Search Start Over

بررسی اثرات مصرف رزوراترول بر روی میزان اوروتنسین 2 و گیرنده آن در بافت قلب رتهای دیابتی

Authors :
خليل پورخليلي
صمد اکبرزاده
رحيميکي
علي موحد
خديجه قاسمي
رامين سيديان
مرضيه محمودی
Source :
Iranian South Medical Journal. Jul2020, Vol. 23 Issue 3, p236-247. 12p.
Publication Year :
2020

Abstract

Background: Individuals with diabetes mellitus are at serious risk of a wide range of cardiovascular complications. Urotensin 2 and its receptors play an important role in the development of cardiovascular diseeases through production of reactive oxygen species (ROS). Resveratrol is a polyphenol with antioxidant and anti-diabetic properties. The present study aimed to investigate the effects of resveratrol on urotensin 2 and its receptors in the heart tissues of diabetic rats. Materials and Methods: In this experimental study, 48 male Wistar rats were divided into six groups (N= 8 in each group). Resveratrol was prepared in 0.5% carboxymethyl cellulose and given to the rats through oral gavage. At the end of the 60 days of treatment with resveratrol, rats’ heart tissue was collected. Results: The weight of diabetic rats treated with 10 and 90 mg/kg bw of resveratrol significantly increased compared with the diabetic group. Furthermore, the serum levels of FBS, lipids, MDA, CK-MB and LDH decreased in the treated diabetic rats compared with the control group. Moreover, concentration of urotensin 2 and its receptors significantly decreased in the heart tissues of the diabetic rats treated with resveratrol at the dose of 10 mg/kg bw compared with the control group. Conclusion: The current study indicated that resveratrol decreased FBS, lipids, weight, MDA and cardiac enzymes. Furthermore, resveratrol significantly reduced urotensin 2 and its receptors, which indicates its moderating effect on diabetes complications. [ABSTRACT FROM AUTHOR]

Details

Language :
Arabic
ISSN :
17354374
Volume :
23
Issue :
3
Database :
Academic Search Index
Journal :
Iranian South Medical Journal
Publication Type :
Academic Journal
Accession number :
145027951